Comparison of Un-roofing Curettage With Rhomboid Excision and Modified Limberg Flap

Sponsor
Konya Meram State Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT04334681
Collaborator
(none)
278
1
6
46.5

Study Details

Study Description

Brief Summary

In our hospital, between January 2013 and January 2017, those operated with the Modified Limberg flap method after the Rhomboid excision due to pilonidal disease, and those operated with the un-roofing curettage method will be screened retrospectively. Patients will be divided into two groups as Un-roofing curettage group (UC group) and the Modified Limberg Flap group (LF group). Operation time, hospital stay time, return to work time, recovery time, Time to walk without pain, days, Time to sit on the toilet without pain, days, Postoperative VAS and recurrence will be compared between both groups

Condition or Disease Intervention/Treatment Phase
  • Procedure: Un-roofing curettage method
  • Procedure: Modified Limberg Flap Group

Detailed Description

In our hospital, between January 2013 and January 2017, those operated with the Modified Limberg flap method after the Rhomboid excision due to pilonidal disease, and those operated with the un-roofing curettage method will be screened retrospectively. Patients who are well followed up will be included in the study. Demographic features will be recorded. Patients will be divided into two groups, the un-roofing curettage group (UC group) and the Modified Limberg Flap group (LF group). Surgery time, hospital stay, return to work time, recovery time, painless walking time, days, painless sitting time in the toilet, days, postoperative VAS, and recurrence will be compared between both groups. In addition, mobilization time, days, recovery time, days, exclusion time, days, wound infection, wound distribution will be compared between groups. The results will be analyzed with the SPSS statistics program. Factors affecting recurrence wound infection, recovery time, hospital stay, operation time, early mobilization will be evaluated by univariate and multivariate logistic regression analysis.

Study Design

Study Type:
Observational
Actual Enrollment :
278 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
Comparison of Un-roofing Curettage With Rhomboid Excision and Modified Limberg Flap in the Surgical Treatment of Pilonidal Disease; A Retrospective Cohort Study
Actual Study Start Date :
Apr 2, 2020
Actual Primary Completion Date :
Sep 15, 2020
Actual Study Completion Date :
Oct 1, 2020

Arms and Interventions

Arm Intervention/Treatment
UC Group

Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group.

Procedure: Un-roofing curettage method
In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.

LF Group

Patients who have been operated with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group.

Procedure: Modified Limberg Flap Group
In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.

Outcome Measures

Primary Outcome Measures

  1. Mobilization Time,Days [15 days]

    Time to return to the daily activities of the patients were measured.

  2. Number of Participants With Recurring Disease [Number of Participants with Recurring Disease, up to five years]

    It has been reported in the literature that a five or ten year follow-up period is required for the effective evaluation of recurrence. In both groups, the number of recurrent patients during the follow-up period will be determined. Observation of the following findings on physical examination made a diagnosis of recurrence; New sinus orifice formation, Or discharge from the sinus orifice

  3. Operation Time [operation time, up to 100 minutes]

    Mean operation time was determined in minutes in both groups.

  4. Hospitalization Time [Hospitalization time, up to 15 days]

    In both groups, hospitalization will be determined as a day.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients between the ages of 18 and 70

  • Patients with sufficient registration information

  • Telephone-accessible patients

Exclusion Criteria:
  • Patients under the age of 18

  • Patients over 70 years old

  • Common gluteal disease

  • Diabetes mellitus

  • Connective tissue disease

Contacts and Locations

Locations

Site City State Country Postal Code
1 Konya Training and Research Hospital Konya Turkey 42090

Sponsors and Collaborators

  • Konya Meram State Hospital

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Alpaslan Şahin, principal investigator, Konya Meram State Hospital
ClinicalTrials.gov Identifier:
NCT04334681
Other Study ID Numbers:
  • pilonidal surgery group
First Posted:
Apr 6, 2020
Last Update Posted:
Feb 8, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

Participant Flow

Recruitment Details
Pre-assignment Detail When we planned to study, we estimated 200 patients. However, we reached 278 patient data and analyzed them.
Arm/Group Title UC Group LF Group
Arm/Group Description Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method.
Period Title: Overall Study
STARTED 135 143
COMPLETED 135 143
NOT COMPLETED 0 0

Baseline Characteristics

Arm/Group Title UC Group LF Group Total
Arm/Group Description Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method. Total of all reporting groups
Overall Participants 135 143 278
Age (years) [Mean (Standard Deviation) ]
Mean (Standard Deviation) [years]
25.35
(8.9)
26.42
(7.9)
25.90
(8.40)
Sex: Female, Male (Count of Participants)
Female
20
14.8%
16
11.2%
36
12.9%
Male
115
85.2%
127
88.8%
242
87.1%
Race and Ethnicity Not Collected (Count of Participants)
Count of Participants [Participants]
0
0%
Region of Enrollment (participants) [Number]
Turkey
135
100%
143
100%
278
100%

Outcome Measures

1. Primary Outcome
Title Mobilization Time,Days
Description Time to return to the daily activities of the patients were measured.
Time Frame 15 days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title UC Group MLF Group
Arm/Group Description Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.
Measure Participants 135 143
Median (Standard Deviation) [days]
3.21
(3.7)
12.3
(7.3)
2. Primary Outcome
Title Number of Participants With Recurring Disease
Description It has been reported in the literature that a five or ten year follow-up period is required for the effective evaluation of recurrence. In both groups, the number of recurrent patients during the follow-up period will be determined. Observation of the following findings on physical examination made a diagnosis of recurrence; New sinus orifice formation, Or discharge from the sinus orifice
Time Frame Number of Participants with Recurring Disease, up to five years

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title MLF Group UC Group
Arm/Group Description Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method. Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis.
Measure Participants 143 135
Number [participants]
6
4.4%
2
1.4%
3. Primary Outcome
Title Operation Time
Description Mean operation time was determined in minutes in both groups.
Time Frame operation time, up to 100 minutes

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title UC Group MLF Group
Arm/Group Description Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.
Measure Participants 135 143
Mean (Standard Deviation) [minute]
11.44
(3.56)
52.47
(7.92)
4. Primary Outcome
Title Hospitalization Time
Description In both groups, hospitalization will be determined as a day.
Time Frame Hospitalization time, up to 15 days

Outcome Measure Data

Analysis Population Description
[Not Specified]
Arm/Group Title UC Group MLF Group
Arm/Group Description Patients operated on the un-roofing curettage method in treating the pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the pilonidal cyst roof is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated on with the modified Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Modified Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the modified Limberg flap method.
Measure Participants 135 143
Mean (Standard Deviation) [days]
0.24
(0.45)
1.07
(0.26)

Adverse Events

Time Frame 6 months
Adverse Event Reporting Description
Arm/Group Title UC Group LF Group
Arm/Group Description Patients operated on the un-roofing curettage method in the treatment of pilonidal disease will be analyzed in this group. Un-roofing curettage method: In this method, the roof of the pilonidal cyst is opened, and the inside is cleaned, and curettage is performed. The wound is closed with a dressing after hemostasis. Patients who have been operated with the Limberg flap method after rhomboid excision in the treatment of pilonidal disease will be analyzed in this group. Limberg Flap Group: In this method, the pilonidal cyst is excised with a rhomboid incision and closed with the Limberg flap method.
All Cause Mortality
UC Group LF Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 0/135 (0%) 0/143 (0%)
Serious Adverse Events
UC Group LF Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 1/135 (0.7%) 2/143 (1.4%)
Injury, poisoning and procedural complications
Hemorrhage 1/135 (0.7%) 1 1/143 (0.7%) 1
Hematoma 0/135 (0%) 0 1/143 (0.7%) 1
Other (Not Including Serious) Adverse Events
UC Group LF Group
Affected / at Risk (%) # Events Affected / at Risk (%) # Events
Total 2/135 (1.5%) 12/143 (8.4%)
Skin and subcutaneous tissue disorders
Wound İnfection 2/135 (1.5%) 2 8/143 (5.6%) 8
Wound dehiscence 0/135 (0%) 0 4/143 (2.8%) 4

Limitations/Caveats

[Not Specified]

More Information

Certain Agreements

Principal Investigators are NOT employed by the organization sponsoring the study.

There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.

Results Point of Contact

Name/Title Dr. Alpaslan Şahin
Organization prinipal investigator
Phone 0332310500 ext 50510
Email drasahin@gmail.com
Responsible Party:
Alpaslan Şahin, principal investigator, Konya Meram State Hospital
ClinicalTrials.gov Identifier:
NCT04334681
Other Study ID Numbers:
  • pilonidal surgery group
First Posted:
Apr 6, 2020
Last Update Posted:
Feb 8, 2021
Last Verified:
Jan 1, 2021